Cargando…

LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use

Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) created an ABCD tool to assess staging and severity of COPD subgroups that respond to LAMA or LABA with improved quality of life and reduced exacerbations. Our study assesses perception of physicians at five community hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Boryushkina, Varvara, Kumar, Vikas, Barnes, Martin, Nabeel, Shaha, Le, Thuy, Siddique, Haseeb, Haggerty, Greg, Ng, Joseph, Kaell, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427455/
https://www.ncbi.nlm.nih.gov/pubmed/32850089
http://dx.doi.org/10.1080/20009666.2020.1786915
_version_ 1783570880806256640
author Boryushkina, Varvara
Kumar, Vikas
Barnes, Martin
Nabeel, Shaha
Le, Thuy
Siddique, Haseeb
Haggerty, Greg
Ng, Joseph
Kaell, Alan
author_facet Boryushkina, Varvara
Kumar, Vikas
Barnes, Martin
Nabeel, Shaha
Le, Thuy
Siddique, Haseeb
Haggerty, Greg
Ng, Joseph
Kaell, Alan
author_sort Boryushkina, Varvara
collection PubMed
description Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) created an ABCD tool to assess staging and severity of COPD subgroups that respond to LAMA or LABA with improved quality of life and reduced exacerbations. Our study assesses perception of physicians at five community hospitals towards LAMA use for patients admitted with COPD exacerbations according to the GOLD guidelines and describes the experience at our hospital. Methods: Electronic survey forms regarding LAMA use and the GOLD criteria ABCD for COPD treating physicians were sent to five hospitals. A one-year chart review at our hospital determined prevalent use of a maintenance LAMA or LABA inhaler in patients admitted with acute COPD exacerbation. Currently, our EMR does not require a field for the GOLD ABCD categorization. Results: We obtained a 33% (45/136) response rate. Of these, 63% felt a LAMA to be essential on formulary; 60% were neutral or unlikely to initiate LAMA on admission; 47.7% likely or very likely to start a LAMA during hospitalization; 82% were neutral to very likely to discharge a patient on a LAMA if deemed necessary for maintenance. Of those admitted for acute COPD exacerbations to our hospital, over a third of COPD patients were not on a maintenance LAMA or LABA. Conclusions: Most physicians felt it important to prescribe a maintenance LAMA to COPD patients hospitalized for acute exacerbation. Our hospital’s use of LAMA or LABA demonstrates the need to incorporate strategies to encourage appropriate prescribing of these LA inhalers per GOLD guidelines.
format Online
Article
Text
id pubmed-7427455
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-74274552020-08-25 LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use Boryushkina, Varvara Kumar, Vikas Barnes, Martin Nabeel, Shaha Le, Thuy Siddique, Haseeb Haggerty, Greg Ng, Joseph Kaell, Alan J Community Hosp Intern Med Perspect Brief Report Background: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) created an ABCD tool to assess staging and severity of COPD subgroups that respond to LAMA or LABA with improved quality of life and reduced exacerbations. Our study assesses perception of physicians at five community hospitals towards LAMA use for patients admitted with COPD exacerbations according to the GOLD guidelines and describes the experience at our hospital. Methods: Electronic survey forms regarding LAMA use and the GOLD criteria ABCD for COPD treating physicians were sent to five hospitals. A one-year chart review at our hospital determined prevalent use of a maintenance LAMA or LABA inhaler in patients admitted with acute COPD exacerbation. Currently, our EMR does not require a field for the GOLD ABCD categorization. Results: We obtained a 33% (45/136) response rate. Of these, 63% felt a LAMA to be essential on formulary; 60% were neutral or unlikely to initiate LAMA on admission; 47.7% likely or very likely to start a LAMA during hospitalization; 82% were neutral to very likely to discharge a patient on a LAMA if deemed necessary for maintenance. Of those admitted for acute COPD exacerbations to our hospital, over a third of COPD patients were not on a maintenance LAMA or LABA. Conclusions: Most physicians felt it important to prescribe a maintenance LAMA to COPD patients hospitalized for acute exacerbation. Our hospital’s use of LAMA or LABA demonstrates the need to incorporate strategies to encourage appropriate prescribing of these LA inhalers per GOLD guidelines. Taylor & Francis 2020-08-02 /pmc/articles/PMC7427455/ /pubmed/32850089 http://dx.doi.org/10.1080/20009666.2020.1786915 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Report
Boryushkina, Varvara
Kumar, Vikas
Barnes, Martin
Nabeel, Shaha
Le, Thuy
Siddique, Haseeb
Haggerty, Greg
Ng, Joseph
Kaell, Alan
LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
title LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
title_full LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
title_fullStr LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
title_full_unstemmed LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
title_short LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
title_sort la inhalers for copd: perceptions/reality of abcd gold tool use
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427455/
https://www.ncbi.nlm.nih.gov/pubmed/32850089
http://dx.doi.org/10.1080/20009666.2020.1786915
work_keys_str_mv AT boryushkinavarvara lainhalersforcopdperceptionsrealityofabcdgoldtooluse
AT kumarvikas lainhalersforcopdperceptionsrealityofabcdgoldtooluse
AT barnesmartin lainhalersforcopdperceptionsrealityofabcdgoldtooluse
AT nabeelshaha lainhalersforcopdperceptionsrealityofabcdgoldtooluse
AT lethuy lainhalersforcopdperceptionsrealityofabcdgoldtooluse
AT siddiquehaseeb lainhalersforcopdperceptionsrealityofabcdgoldtooluse
AT haggertygreg lainhalersforcopdperceptionsrealityofabcdgoldtooluse
AT ngjoseph lainhalersforcopdperceptionsrealityofabcdgoldtooluse
AT kaellalan lainhalersforcopdperceptionsrealityofabcdgoldtooluse